Literature DB >> 8228813

Pim-1 levels determine the size of early B lymphoid compartments in bone marrow.

J Domen1, N M van der Lugt, D Acton, P W Laird, K Linders, A Berns.   

Abstract

The mouse proto-oncogene Pim-1, which encodes two cytoplasmic serine-threonine-specific protein kinases, is frequently activated by proviral insertion in murine leukemia virus-induced hematopoietic tumors. Transgenic mice overexpressing Pim-1 show a low incidence of spontaneous T cell lymphomas, whereas null mutant mice lack an obvious phenotype. We have analyzed the early B lymphoid compartment from both null mutant and E mu-Pim-1 transgenic mice. The level of Pim-1 expression appears to be a determining factor in the ability of these cells to respond to the growth factors interleukin 7 (IL-7) and SF (steel factor). The impaired response in null mutant mice could be rescued by introduction of a functional Pim-1 transgene. Moreover, overexpression of Pim-1 facilitates the derivation of primitive lymphoid cell lines that are dependent on combined stimulation with IL-7 and SF or insulin-like growth factor 1. These results for the first time identify the involvement of Pim-1 in a normal cellular function, as an important regulator of early B lymphopoiesis in mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228813      PMCID: PMC2191259          DOI: 10.1084/jem.178.5.1665

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  49 in total

1.  The epigenetic influences of bone marrow and fetal liver stroma cells on the developmental potential of Ly-1+ pro-B lymphocyte clones.

Authors:  R Palacios; S Stuber; A Rolink
Journal:  Eur J Immunol       Date:  1989-02       Impact factor: 5.532

2.  Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta.

Authors:  G Lee; A E Namen; S Gillis; L R Ellingsworth; P W Kincade
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

3.  PB76: a novel surface glycoprotein preferentially expressed on mouse pre-B cells and plasma cells detected by the monoclonal antibody G-5-2.

Authors:  A Strasser
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

4.  Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.

Authors:  M van Lohuizen; S Verbeek; P Krimpenfort; J Domen; C Saris; T Radaszkiewicz; A Berns
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

5.  Identification of a new cell surface glycoprotein with accessory function in murine T cell responses.

Authors:  W T Golde; M McDuffie; J Kappler; P Marrack
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

6.  T cell depletion in transgenic mice carrying a mutant gene for TCR-beta.

Authors:  P Krimpenfort; F Ossendorp; J Borst; C Melief; A Berns
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

7.  Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl.

Authors:  J L Cleveland; M Dean; N Rosenberg; J Y Wang; U R Rapp
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

8.  Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells.

Authors:  J Domen; N M van der Lugt; P W Laird; C J Saris; A R Clarke; M L Hooper; A Berns
Journal:  Blood       Date:  1993-09-01       Impact factor: 22.113

9.  The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow.

Authors:  I Förster; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

10.  Human P40/IL-9. Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene.

Authors:  J C Renauld; A Goethals; F Houssiau; H Merz; E Van Roost; J Van Snick
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

View more
  25 in total

1.  Pim kinase expression is induced by LTP stimulation and required for the consolidation of enduring LTP.

Authors:  U Konietzko; G Kauselmann; J Scafidi; U Staubli; H Mikkers; A Berns; M Schweizer; R Waltereit; D Kuhl
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

Review 2.  For better or for worse: the role of Pim oncogenes in tumorigenesis.

Authors:  Martijn C Nawijn; Andrej Alendar; Anton Berns
Journal:  Nat Rev Cancer       Date:  2010-12-09       Impact factor: 60.716

3.  Hoxa9 regulates Flt3 in lymphohematopoietic progenitors.

Authors:  Kimberly Gwin; Elena Frank; Ayoko Bossou; Kay L Medina
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

Review 4.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

5.  Integrated signaling in developing lymphocytes: the role of DNA damage responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

6.  Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells.

Authors:  Ningfei An; Ying-Wei Lin; Sandeep Mahajan; Joshua N Kellner; Yong Wang; Zihai Li; Andrew S Kraft; Yubin Kang
Journal:  Stem Cells       Date:  2013-06       Impact factor: 6.277

7.  A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma.

Authors:  Ying-Wei Lin; Zanna M Beharry; Elizabeth G Hill; Jin H Song; Wenxue Wang; Zuping Xia; Zhenhua Zhang; Peter D Aplan; Jon C Aster; Charles D Smith; Andrew S Kraft
Journal:  Blood       Date:  2009-11-23       Impact factor: 22.113

Review 8.  Lymphocyte development: integration of DNA damage response signaling.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Adv Immunol       Date:  2012       Impact factor: 3.543

Review 9.  Transgenic and gene knockout mice in cancer research.

Authors:  J L Viney
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

10.  Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.

Authors:  Harald Mikkers; Martijn Nawijn; John Allen; Conny Brouwers; Els Verhoeven; Jos Jonkers; Anton Berns
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.